

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.95271094 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.77689749 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 5.77689749 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.61418151 |
| 5 | respiratory electron transport chain (GO:0022904) | 5.39523397 |
| 6 | protein complex biogenesis (GO:0070271) | 5.38278513 |
| 7 | electron transport chain (GO:0022900) | 5.35743420 |
| 8 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 5.02278523 |
| 9 | NADH dehydrogenase complex assembly (GO:0010257) | 5.02278523 |
| 10 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 5.02278523 |
| 11 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.81742499 |
| 12 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.59164928 |
| 13 | DNA deamination (GO:0045006) | 4.44860767 |
| 14 | respiratory chain complex IV assembly (GO:0008535) | 4.35298588 |
| 15 | proteasome assembly (GO:0043248) | 4.22631230 |
| 16 | cytochrome complex assembly (GO:0017004) | 4.20526496 |
| 17 | chaperone-mediated protein transport (GO:0072321) | 4.06592119 |
| 18 | metallo-sulfur cluster assembly (GO:0031163) | 3.89332898 |
| 19 | iron-sulfur cluster assembly (GO:0016226) | 3.89332898 |
| 20 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.82325954 |
| 21 | hydrogen ion transmembrane transport (GO:1902600) | 3.78467097 |
| 22 | ATP biosynthetic process (GO:0006754) | 3.74613761 |
| 23 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.69003894 |
| 24 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.68296407 |
| 25 | regulation of mitochondrial translation (GO:0070129) | 3.68039034 |
| 26 | mannosylation (GO:0097502) | 3.56019115 |
| 27 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.55416961 |
| 28 | termination of RNA polymerase III transcription (GO:0006386) | 3.55416961 |
| 29 | proton transport (GO:0015992) | 3.53184228 |
| 30 | ubiquinone biosynthetic process (GO:0006744) | 3.51724440 |
| 31 | hydrogen transport (GO:0006818) | 3.48654645 |
| 32 | GTP biosynthetic process (GO:0006183) | 3.48291454 |
| 33 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.46629217 |
| 34 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.46629217 |
| 35 | platelet dense granule organization (GO:0060155) | 3.43113897 |
| 36 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.42860306 |
| 37 | protein neddylation (GO:0045116) | 3.40629411 |
| 38 | protein targeting to mitochondrion (GO:0006626) | 3.37366554 |
| 39 | establishment of protein localization to mitochondrion (GO:0072655) | 3.34261098 |
| 40 | rRNA modification (GO:0000154) | 3.29791026 |
| 41 | oxidative phosphorylation (GO:0006119) | 3.29267980 |
| 42 | peptidyl-histidine modification (GO:0018202) | 3.24931129 |
| 43 | protein maturation by protein folding (GO:0022417) | 3.20331895 |
| 44 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.12224384 |
| 45 | pseudouridine synthesis (GO:0001522) | 3.07685882 |
| 46 | autophagic vacuole fusion (GO:0000046) | 3.06411074 |
| 47 | positive regulation of prostaglandin secretion (GO:0032308) | 3.03990425 |
| 48 | protein localization to mitochondrion (GO:0070585) | 3.03865366 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 2.99781360 |
| 50 | response to pheromone (GO:0019236) | 2.97772903 |
| 51 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.97478525 |
| 52 | ubiquinone metabolic process (GO:0006743) | 2.91873831 |
| 53 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.91299691 |
| 54 | protein deneddylation (GO:0000338) | 2.91051708 |
| 55 | response to interferon-beta (GO:0035456) | 2.91012025 |
| 56 | ribosomal small subunit assembly (GO:0000028) | 2.89563625 |
| 57 | mitochondrial transport (GO:0006839) | 2.88859333 |
| 58 | GDP-mannose metabolic process (GO:0019673) | 2.86787459 |
| 59 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.85131163 |
| 60 | cullin deneddylation (GO:0010388) | 2.85105205 |
| 61 | inner mitochondrial membrane organization (GO:0007007) | 2.84279205 |
| 62 | UTP biosynthetic process (GO:0006228) | 2.82455570 |
| 63 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.82306560 |
| 64 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.81944057 |
| 65 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.81944057 |
| 66 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.81944057 |
| 67 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.81587496 |
| 68 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.81587496 |
| 69 | base-excision repair, AP site formation (GO:0006285) | 2.81435582 |
| 70 | quinone biosynthetic process (GO:1901663) | 2.81295121 |
| 71 | aerobic respiration (GO:0009060) | 2.80849167 |
| 72 | regulation of cilium movement (GO:0003352) | 2.78679727 |
| 73 | protein-cofactor linkage (GO:0018065) | 2.77801153 |
| 74 | cellular response to interferon-beta (GO:0035458) | 2.76557495 |
| 75 | ribosomal small subunit biogenesis (GO:0042274) | 2.75785846 |
| 76 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.75521995 |
| 77 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.75521995 |
| 78 | cellular component biogenesis (GO:0044085) | 2.74774591 |
| 79 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.74743580 |
| 80 | viral transcription (GO:0019083) | 2.73341755 |
| 81 | ketone body metabolic process (GO:1902224) | 2.73278712 |
| 82 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.72943417 |
| 83 | behavioral response to nicotine (GO:0035095) | 2.72504124 |
| 84 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.72365440 |
| 85 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.71821682 |
| 86 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.70377368 |
| 87 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.69349282 |
| 88 | protein localization to endoplasmic reticulum (GO:0070972) | 2.66929877 |
| 89 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.66647940 |
| 90 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.66647940 |
| 91 | protein targeting to ER (GO:0045047) | 2.66299514 |
| 92 | cellular response to zinc ion (GO:0071294) | 2.65696846 |
| 93 | negative regulation of ligase activity (GO:0051352) | 2.65477243 |
| 94 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.65477243 |
| 95 | organelle membrane fusion (GO:0090174) | 2.64916591 |
| 96 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.64536724 |
| 97 | cotranslational protein targeting to membrane (GO:0006613) | 2.62839217 |
| 98 | intracellular protein transmembrane import (GO:0044743) | 2.62252407 |
| 99 | translation (GO:0006412) | 2.61836469 |
| 100 | UTP metabolic process (GO:0046051) | 2.61272254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.03911499 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.94506955 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.75125355 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.72942157 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.56299453 |
| 6 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.20104260 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.16117621 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.95289172 |
| 9 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.81279187 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.76666363 |
| 11 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.60377990 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.55234637 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.51560849 |
| 14 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.37741809 |
| 15 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.14452026 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.09586344 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.97503451 |
| 18 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.97367066 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93176873 |
| 20 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.93065986 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.91310641 |
| 22 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.90989119 |
| 23 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.86448011 |
| 24 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.81811783 |
| 25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.81514463 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.80404895 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78346221 |
| 28 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.77427118 |
| 29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.76372136 |
| 30 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.72806604 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.67174348 |
| 32 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.64275113 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.60660358 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59876714 |
| 35 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.59382963 |
| 36 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.55189091 |
| 37 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.54558074 |
| 38 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.53943840 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.52454042 |
| 40 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.48066919 |
| 41 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.46488590 |
| 42 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.46046457 |
| 43 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.45727127 |
| 44 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.44212090 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43611987 |
| 46 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42864749 |
| 47 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.41426833 |
| 48 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.41299578 |
| 49 | P68_20966046_ChIP-Seq_HELA_Human | 1.39769449 |
| 50 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.39164563 |
| 51 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.38018542 |
| 52 | ERA_21632823_ChIP-Seq_H3396_Human | 1.35680924 |
| 53 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.34970737 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34168097 |
| 55 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.33379448 |
| 56 | P300_27268052_Chip-Seq_Bcells_Human | 1.32053168 |
| 57 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.31290473 |
| 58 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.28178095 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27510886 |
| 60 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.25799446 |
| 61 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.25667784 |
| 62 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.25157200 |
| 63 | SA1_27219007_Chip-Seq_Bcells_Human | 1.24328037 |
| 64 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.24295077 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.22832195 |
| 66 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.22272958 |
| 67 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.20657828 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18512654 |
| 69 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18260464 |
| 70 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.17277705 |
| 71 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.15771487 |
| 72 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.10677737 |
| 73 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09247289 |
| 74 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.08711722 |
| 75 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08028437 |
| 76 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.07659094 |
| 77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07149208 |
| 78 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.07130488 |
| 79 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05507009 |
| 80 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.04170346 |
| 81 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.04164907 |
| 82 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.03542119 |
| 83 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.02685740 |
| 84 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.02352646 |
| 85 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.00853459 |
| 86 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.00554611 |
| 87 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.00152743 |
| 88 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00150833 |
| 89 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97350698 |
| 90 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.95967664 |
| 91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.95663361 |
| 92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95151184 |
| 93 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.94935427 |
| 94 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.94637920 |
| 95 | AR_20517297_ChIP-Seq_VCAP_Human | 0.94065981 |
| 96 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.92211595 |
| 97 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.92136252 |
| 98 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.92058627 |
| 99 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90256577 |
| 100 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.90164858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.48783665 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.47062626 |
| 3 | MP0006036_abnormal_mitochondrial_physio | 3.09025314 |
| 4 | MP0003646_muscle_fatigue | 2.86166808 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 2.44633422 |
| 6 | MP0000372_irregular_coat_pigmentation | 2.43068297 |
| 7 | MP0003186_abnormal_redox_activity | 2.42131405 |
| 8 | MP0003011_delayed_dark_adaptation | 2.38572168 |
| 9 | MP0005410_abnormal_fertilization | 2.35329227 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 2.20234375 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.14836070 |
| 12 | MP0001905_abnormal_dopamine_level | 2.07601917 |
| 13 | MP0002653_abnormal_ependyma_morphology | 1.75241398 |
| 14 | MP0005671_abnormal_response_to | 1.74878216 |
| 15 | MP0004147_increased_porphyrin_level | 1.74668667 |
| 16 | MP0003195_calcinosis | 1.69341291 |
| 17 | MP0005645_abnormal_hypothalamus_physiol | 1.62424957 |
| 18 | MP0005084_abnormal_gallbladder_morpholo | 1.62294029 |
| 19 | MP0000749_muscle_degeneration | 1.62076216 |
| 20 | MP0001968_abnormal_touch/_nociception | 1.59144580 |
| 21 | MP0009046_muscle_twitch | 1.58600797 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 1.55211546 |
| 23 | MP0005670_abnormal_white_adipose | 1.54665614 |
| 24 | MP0005332_abnormal_amino_acid | 1.53816976 |
| 25 | MP0005551_abnormal_eye_electrophysiolog | 1.52251120 |
| 26 | MP0009379_abnormal_foot_pigmentation | 1.50733024 |
| 27 | MP0008872_abnormal_physiological_respon | 1.48754882 |
| 28 | MP0004142_abnormal_muscle_tone | 1.48682015 |
| 29 | MP0003950_abnormal_plasma_membrane | 1.45975691 |
| 30 | MP0005379_endocrine/exocrine_gland_phen | 1.45509569 |
| 31 | MP0006035_abnormal_mitochondrial_morpho | 1.44310189 |
| 32 | MP0006072_abnormal_retinal_apoptosis | 1.41713565 |
| 33 | MP0001764_abnormal_homeostasis | 1.41185119 |
| 34 | MP0009745_abnormal_behavioral_response | 1.37053940 |
| 35 | MP0002736_abnormal_nociception_after | 1.34776695 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.34428351 |
| 37 | MP0003786_premature_aging | 1.33710525 |
| 38 | MP0009840_abnormal_foam_cell | 1.30766075 |
| 39 | MP0004043_abnormal_pH_regulation | 1.29600184 |
| 40 | MP0005075_abnormal_melanosome_morpholog | 1.29339723 |
| 41 | MP0009785_altered_susceptibility_to | 1.29021756 |
| 42 | MP0002163_abnormal_gland_morphology | 1.26564731 |
| 43 | MP0009764_decreased_sensitivity_to | 1.19570314 |
| 44 | MP0000343_altered_response_to | 1.19095253 |
| 45 | MP0002272_abnormal_nervous_system | 1.18502825 |
| 46 | MP0002638_abnormal_pupillary_reflex | 1.18254025 |
| 47 | MP0002102_abnormal_ear_morphology | 1.18148375 |
| 48 | MP0008775_abnormal_heart_ventricle | 1.13964819 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 1.13740557 |
| 50 | MP0002693_abnormal_pancreas_physiology | 1.12920921 |
| 51 | MP0005165_increased_susceptibility_to | 1.11172529 |
| 52 | MP0001970_abnormal_pain_threshold | 1.10107669 |
| 53 | MP0001853_heart_inflammation | 1.07561290 |
| 54 | MP0005365_abnormal_bile_salt | 1.06633787 |
| 55 | MP0005330_cardiomyopathy | 1.05742979 |
| 56 | MP0001529_abnormal_vocalization | 1.05395316 |
| 57 | MP0010386_abnormal_urinary_bladder | 1.05079161 |
| 58 | MP0002064_seizures | 1.04867222 |
| 59 | MP0000750_abnormal_muscle_regeneration | 1.04508332 |
| 60 | MP0001984_abnormal_olfaction | 1.02959204 |
| 61 | MP0000685_abnormal_immune_system | 1.01693216 |
| 62 | MP0005389_reproductive_system_phenotype | 1.01399083 |
| 63 | MP0001986_abnormal_taste_sensitivity | 1.01297708 |
| 64 | MP0001542_abnormal_bone_strength | 1.00992849 |
| 65 | MP0001919_abnormal_reproductive_system | 0.99203795 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 0.98930381 |
| 67 | MP0009643_abnormal_urine_homeostasis | 0.98552049 |
| 68 | MP0003137_abnormal_impulse_conducting | 0.98507970 |
| 69 | MP0003075_altered_response_to | 0.95825951 |
| 70 | MP0005360_urolithiasis | 0.95762042 |
| 71 | MP0001501_abnormal_sleep_pattern | 0.94401219 |
| 72 | MP0002733_abnormal_thermal_nociception | 0.91021305 |
| 73 | MP0002160_abnormal_reproductive_system | 0.90644542 |
| 74 | MP0005253_abnormal_eye_physiology | 0.89742960 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 0.85715812 |
| 76 | MP0005266_abnormal_metabolism | 0.85251226 |
| 77 | MP0005535_abnormal_body_temperature | 0.85008228 |
| 78 | MP0005083_abnormal_biliary_tract | 0.83843862 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83176006 |
| 80 | MP0001756_abnormal_urination | 0.82162787 |
| 81 | MP0005408_hypopigmentation | 0.81931373 |
| 82 | MP0008058_abnormal_DNA_repair | 0.81595840 |
| 83 | MP0008469_abnormal_protein_level | 0.80918296 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 0.80579973 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 0.80414550 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.80265731 |
| 87 | MP0003880_abnormal_central_pattern | 0.80115070 |
| 88 | MP0004215_abnormal_myocardial_fiber | 0.78498113 |
| 89 | MP0000747_muscle_weakness | 0.77035390 |
| 90 | MP0002572_abnormal_emotion/affect_behav | 0.76418919 |
| 91 | MP0003638_abnormal_response/metabolism_ | 0.76148337 |
| 92 | MP0005423_abnormal_somatic_nervous | 0.75130946 |
| 93 | MP0000230_abnormal_systemic_arterial | 0.74706173 |
| 94 | MP0005058_abnormal_lysosome_morphology | 0.74531218 |
| 95 | MP0001835_abnormal_antigen_presentation | 0.74229619 |
| 96 | MP0000358_abnormal_cell_content/ | 0.73921861 |
| 97 | MP0002909_abnormal_adrenal_gland | 0.73851483 |
| 98 | MP0005025_abnormal_response_to | 0.73748413 |
| 99 | MP0001790_abnormal_immune_system | 0.71535720 |
| 100 | MP0005387_immune_system_phenotype | 0.71535720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.56105841 |
| 2 | Mitochondrial inheritance (HP:0001427) | 5.44936655 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.43850422 |
| 4 | Hepatocellular necrosis (HP:0001404) | 5.02643999 |
| 5 | Acute encephalopathy (HP:0006846) | 4.86413059 |
| 6 | Increased CSF lactate (HP:0002490) | 4.82169594 |
| 7 | Hepatic necrosis (HP:0002605) | 4.66499593 |
| 8 | Progressive macrocephaly (HP:0004481) | 4.63170993 |
| 9 | Increased intramyocellular lipid droplets (HP:0012240) | 4.19785356 |
| 10 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.11799867 |
| 11 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.11799867 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.91341034 |
| 13 | Renal Fanconi syndrome (HP:0001994) | 3.89951178 |
| 14 | Increased muscle lipid content (HP:0009058) | 3.79974778 |
| 15 | Lipid accumulation in hepatocytes (HP:0006561) | 3.73802223 |
| 16 | Lactic acidosis (HP:0003128) | 3.48343681 |
| 17 | Cerebral edema (HP:0002181) | 3.46948438 |
| 18 | Increased serum lactate (HP:0002151) | 3.42074587 |
| 19 | 3-Methylglutaconic aciduria (HP:0003535) | 3.35927287 |
| 20 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.32230745 |
| 21 | Respiratory failure (HP:0002878) | 3.19903430 |
| 22 | Exercise intolerance (HP:0003546) | 3.10371905 |
| 23 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.94375328 |
| 24 | Exertional dyspnea (HP:0002875) | 2.90805133 |
| 25 | Optic disc pallor (HP:0000543) | 2.86064166 |
| 26 | Type I transferrin isoform profile (HP:0003642) | 2.73512888 |
| 27 | Type II lissencephaly (HP:0007260) | 2.68844857 |
| 28 | Hyperalaninemia (HP:0003348) | 2.55176230 |
| 29 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.55176230 |
| 30 | Abnormality of alanine metabolism (HP:0010916) | 2.55176230 |
| 31 | Lethargy (HP:0001254) | 2.44475647 |
| 32 | Opisthotonus (HP:0002179) | 2.43982815 |
| 33 | Congenital stationary night blindness (HP:0007642) | 2.41500023 |
| 34 | Testicular atrophy (HP:0000029) | 2.39541011 |
| 35 | Emotional lability (HP:0000712) | 2.39189197 |
| 36 | Progressive microcephaly (HP:0000253) | 2.35755344 |
| 37 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.31434769 |
| 38 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.29647835 |
| 39 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.29647835 |
| 40 | Abnormal protein glycosylation (HP:0012346) | 2.29647835 |
| 41 | Abnormal glycosylation (HP:0012345) | 2.29647835 |
| 42 | Molar tooth sign on MRI (HP:0002419) | 2.28622379 |
| 43 | Abnormality of midbrain morphology (HP:0002418) | 2.28622379 |
| 44 | Methylmalonic aciduria (HP:0012120) | 2.28617995 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28357573 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 2.28357573 |
| 47 | Generalized aminoaciduria (HP:0002909) | 2.27030083 |
| 48 | CNS demyelination (HP:0007305) | 2.26970843 |
| 49 | Abnormal number of erythroid precursors (HP:0012131) | 2.24185589 |
| 50 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.24076211 |
| 51 | Abnormality of urine glucose concentration (HP:0011016) | 2.21793961 |
| 52 | Glycosuria (HP:0003076) | 2.21793961 |
| 53 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.20555211 |
| 54 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19849491 |
| 55 | Absent/shortened dynein arms (HP:0200106) | 2.19849491 |
| 56 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.19553724 |
| 57 | Abnormality of renal resorption (HP:0011038) | 2.17535987 |
| 58 | Pancreatic cysts (HP:0001737) | 2.13140717 |
| 59 | Respiratory difficulties (HP:0002880) | 2.11077181 |
| 60 | Severe muscular hypotonia (HP:0006829) | 2.09102290 |
| 61 | Ketoacidosis (HP:0001993) | 2.05395574 |
| 62 | True hermaphroditism (HP:0010459) | 2.02403601 |
| 63 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.02399891 |
| 64 | Leukodystrophy (HP:0002415) | 2.01126600 |
| 65 | Congenital, generalized hypertrichosis (HP:0004540) | 1.99111349 |
| 66 | Esophageal neoplasm (HP:0100751) | 1.96160234 |
| 67 | Neoplasm of head and neck (HP:0012288) | 1.96160234 |
| 68 | Type 2 muscle fiber atrophy (HP:0003554) | 1.94775463 |
| 69 | Pancreatic fibrosis (HP:0100732) | 1.92406531 |
| 70 | Cerebral palsy (HP:0100021) | 1.91867224 |
| 71 | Microretrognathia (HP:0000308) | 1.91655694 |
| 72 | Myoglobinuria (HP:0002913) | 1.91457403 |
| 73 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.91365346 |
| 74 | Muscle fiber atrophy (HP:0100295) | 1.91333862 |
| 75 | Ketosis (HP:0001946) | 1.89408407 |
| 76 | Severe visual impairment (HP:0001141) | 1.89017679 |
| 77 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.85764825 |
| 78 | Ragged-red muscle fibers (HP:0003200) | 1.84806122 |
| 79 | Abnormality of glycolipid metabolism (HP:0010969) | 1.80218615 |
| 80 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.80218615 |
| 81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.80218615 |
| 82 | Blindness (HP:0000618) | 1.74804179 |
| 83 | Palpitations (HP:0001962) | 1.73158991 |
| 84 | Hyperphosphaturia (HP:0003109) | 1.71208077 |
| 85 | IgG deficiency (HP:0004315) | 1.71038325 |
| 86 | X-linked dominant inheritance (HP:0001423) | 1.69191539 |
| 87 | Sclerocornea (HP:0000647) | 1.69152685 |
| 88 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.69014235 |
| 89 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.69014235 |
| 90 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.68949155 |
| 91 | Vomiting (HP:0002013) | 1.68573442 |
| 92 | Rhabdomyolysis (HP:0003201) | 1.68442709 |
| 93 | Methylmalonic acidemia (HP:0002912) | 1.65993006 |
| 94 | Aplastic anemia (HP:0001915) | 1.65533187 |
| 95 | Nephronophthisis (HP:0000090) | 1.62438008 |
| 96 | Attenuation of retinal blood vessels (HP:0007843) | 1.62230691 |
| 97 | Large for gestational age (HP:0001520) | 1.62036760 |
| 98 | Medial flaring of the eyebrow (HP:0010747) | 1.61264362 |
| 99 | Gliosis (HP:0002171) | 1.60252301 |
| 100 | Abnormality of magnesium homeostasis (HP:0004921) | 1.58970238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.35361557 |
| 2 | NME2 | 3.67595244 |
| 3 | TESK1 | 3.22535036 |
| 4 | BCKDK | 3.19715898 |
| 5 | LIMK1 | 2.88199894 |
| 6 | TESK2 | 2.68086621 |
| 7 | TLK1 | 2.64293662 |
| 8 | PIM2 | 2.59107284 |
| 9 | MAP4K2 | 2.51067918 |
| 10 | ARAF | 2.49671759 |
| 11 | STK16 | 2.09984340 |
| 12 | MAP3K11 | 2.09513780 |
| 13 | MAPKAPK3 | 2.07632771 |
| 14 | ZAK | 1.98891373 |
| 15 | MAPK15 | 1.98363333 |
| 16 | ADRBK2 | 1.96985046 |
| 17 | PHKG2 | 1.96938133 |
| 18 | PHKG1 | 1.96938133 |
| 19 | KDR | 1.96033029 |
| 20 | VRK1 | 1.95965911 |
| 21 | CAMKK2 | 1.93177698 |
| 22 | ABL2 | 1.70632228 |
| 23 | MAP3K12 | 1.62571338 |
| 24 | TXK | 1.57470013 |
| 25 | MUSK | 1.52405884 |
| 26 | GRK1 | 1.51633884 |
| 27 | CSNK1G3 | 1.29753201 |
| 28 | TAOK3 | 1.25375083 |
| 29 | DAPK1 | 1.20242326 |
| 30 | PINK1 | 1.18750085 |
| 31 | OBSCN | 1.16935371 |
| 32 | MYLK | 1.16014766 |
| 33 | NME1 | 1.10140614 |
| 34 | INSRR | 1.09500112 |
| 35 | FRK | 1.08313269 |
| 36 | NUAK1 | 1.08141295 |
| 37 | IKBKB | 1.07218362 |
| 38 | RPS6KA5 | 0.98678974 |
| 39 | CSNK1G2 | 0.98094441 |
| 40 | GRK5 | 0.95836658 |
| 41 | CSNK1G1 | 0.95091823 |
| 42 | TBK1 | 0.93366508 |
| 43 | DAPK2 | 0.92346436 |
| 44 | WNK4 | 0.92127149 |
| 45 | PDK2 | 0.91368109 |
| 46 | DAPK3 | 0.88414703 |
| 47 | PRKCI | 0.87144681 |
| 48 | CSNK1A1L | 0.85925628 |
| 49 | MAP2K6 | 0.84592056 |
| 50 | ILK | 0.83755374 |
| 51 | ADRBK1 | 0.83379362 |
| 52 | DYRK2 | 0.81076604 |
| 53 | BUB1 | 0.80788854 |
| 54 | MAPKAPK5 | 0.77117256 |
| 55 | MAP2K7 | 0.76966541 |
| 56 | BMPR1B | 0.75482436 |
| 57 | GRK7 | 0.74614119 |
| 58 | IRAK3 | 0.72020829 |
| 59 | MAPK13 | 0.70950244 |
| 60 | CDK8 | 0.70439501 |
| 61 | BRAF | 0.70267102 |
| 62 | CAMKK1 | 0.67842417 |
| 63 | AURKA | 0.66750980 |
| 64 | MST4 | 0.64483509 |
| 65 | CAMK2G | 0.58797558 |
| 66 | PKN1 | 0.58240014 |
| 67 | TAOK2 | 0.57902772 |
| 68 | IKBKE | 0.52837460 |
| 69 | WNK3 | 0.52417378 |
| 70 | LMTK2 | 0.49514140 |
| 71 | LRRK2 | 0.48656114 |
| 72 | TIE1 | 0.48425959 |
| 73 | PAK1 | 0.48067519 |
| 74 | NEK1 | 0.47175072 |
| 75 | PAK6 | 0.46704878 |
| 76 | MAP2K2 | 0.46687677 |
| 77 | KIT | 0.46236153 |
| 78 | MAP4K1 | 0.41584436 |
| 79 | OXSR1 | 0.41277125 |
| 80 | PAK3 | 0.40832363 |
| 81 | PTK2B | 0.39725005 |
| 82 | CAMK2A | 0.39236260 |
| 83 | CAMK2D | 0.38900710 |
| 84 | CAMK1 | 0.38185487 |
| 85 | CDK19 | 0.37028598 |
| 86 | PRKACA | 0.34753007 |
| 87 | PRKCA | 0.34354492 |
| 88 | PRKCQ | 0.33765409 |
| 89 | RAF1 | 0.33103403 |
| 90 | GRK6 | 0.32928473 |
| 91 | TNK2 | 0.32749315 |
| 92 | EPHA2 | 0.32339943 |
| 93 | SCYL2 | 0.31587433 |
| 94 | CSNK1A1 | 0.31552611 |
| 95 | PRKCG | 0.30709964 |
| 96 | CSNK2A1 | 0.30502512 |
| 97 | CSNK2A2 | 0.28881635 |
| 98 | CCNB1 | 0.27734222 |
| 99 | PRKCE | 0.27122453 |
| 100 | MAPK11 | 0.26834168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.01332397 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.12656237 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.78578056 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.28662525 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 2.91932385 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.85363360 |
| 7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.64824710 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.54679514 |
| 9 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.25912996 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.23597930 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.13229679 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.95713814 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.80011668 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.65537247 |
| 15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.56616227 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.53376552 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.47370947 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47173043 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37645843 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32925691 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.25260267 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.21174984 |
| 23 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.19457819 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.18542073 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.17896250 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.15408693 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.14621104 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.09961014 |
| 29 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.09051766 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.08627202 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08172985 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.07713464 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.07652785 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.07172015 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 1.06394046 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.04709159 |
| 37 | Base excision repair_Homo sapiens_hsa03410 | 1.02354938 |
| 38 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96060570 |
| 39 | Metabolic pathways_Homo sapiens_hsa01100 | 0.95589240 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95540751 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94079648 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93782158 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90419320 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 0.90293391 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89151883 |
| 46 | DNA replication_Homo sapiens_hsa03030 | 0.87414604 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86133593 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84095005 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.81715368 |
| 50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80810836 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80675248 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79481173 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.77724079 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.76734504 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76503607 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76337963 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76254136 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75690747 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75058153 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72409354 |
| 61 | Mismatch repair_Homo sapiens_hsa03430 | 0.72186144 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71758349 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70590076 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69837862 |
| 65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69741489 |
| 66 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69451946 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67755851 |
| 68 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.66267701 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65160997 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65044457 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64920870 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64246023 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64003129 |
| 74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62057739 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61479926 |
| 76 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.59211194 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58641156 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55959811 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55767013 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55359179 |
| 81 | Basal transcription factors_Homo sapiens_hsa03022 | 0.53017896 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.52610908 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49927813 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.49028978 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46100533 |
| 86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45936315 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44241263 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42739081 |
| 89 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.42716733 |
| 90 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41530642 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.40640968 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.40157592 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40126981 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39451302 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.38717563 |
| 96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37936637 |
| 97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.37796186 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37343870 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35992246 |
| 100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.34560522 |

